2^nd International Conference on Dermatology and Allergic Diseases June 13-14, 2019 Scandic Jarvenpaa | Helsinki, Finland

Colby Evans, MD is the chair of the research committee and the immediate past chair of the board of directors for the National Psoriasis Foundation. He completed his medical degree and residency in dermatology at the University of Texas Southwestern Medical Center in Dallas, followed by a Clinical Fellowship at the St. John’s Institute of Dermatology in London, England. He holds an undergraduate degree from Wesleyan University, where he graduated Phi Beta Kappa with high honors in Chemistry. Dr. Evans has served on many volunteer committees with the American Academy of Dermatology, including the Diversity Taskforce, Workforce Taskforce, and Carrier Policy and Medical Liability Taskforce, and is currently a member of the Performance Measurement Task Force’s Inflammatory Skin Disease/Itch Workgroup. Dr. Evans is also the immediate past of chair of the AAD’s Drug Pricing and Transparency Task Force and was the 2009 President of the Austin Dermatology Society.

Dermatology

Ljudmila Stojanovich received her Ph.D. in Medicine, with the thesis “Neuropsychiatric manifestations in patients with Systemic Lupus Erythematosus” in 1999. She is the scientific director in the Bezhanijska Kosa, University Medical Center of Belgrade University, where she is currently a Full Research Professor. Dr. Stojanovich’s research focuses on Systemic Lupus Erythematosus, Antiphospholipid Syndrome, and Vaccination in patients with Autoimmune Rheumatic diseases. She is an author of three monographs and of about 250 articles on various aspects of Autoimmune Rheumatic disorders, published in international and domestic journals and in conference proceedings. She is in Editorial Boards (Editorial Boards LUPUS (LONDON). /Reviewer in the “CURRENT CONTENSTS” or “Science citation index”, like LUPUS REWIEWER DATABAS, Cellular and Molecular Neurobiology, The Journal of Vaccine

Autoimmune Diseases, Infectious Diseases

Arkadii Frankemberg is a specialist Certification in dermatovenerologist from Ukraine, fully dedicated to his field. He is currently working as the Head Physician at Municipal Institution “Regional Dermatovenerologic Clinic”, Dnipropetrovsk, Ukraine since 1988. He Studied at Dnipropetrovsk State Medical Institute, in Ukraine and later on taking up teaching and research activities after obtaining Masters and PhD from the “Institute of Dermatology and Venereology of the Academy of Medical Sciences of the Ukraine”, Kharkiv, Ukraine. Previously, he was working as Chief Doctor at Dnepropetrovsk Regional Dermatovenerologic Dispensary(1977- 1988).

Dermatology, venereology

Stef Stienstra works internationally for several medical and biotech companies as a scientific advisory board member. He is also an active reserve-officer of the Royal Dutch Navy in his rank as Commander (OF4). For the Dutch Armed Forces, he is CBRNe specialist with a focus on (micro)biological and chemical threats. He is also manager of the group of medical- and environmental functional specialist within the 1st CMI (Civil-Military Interaction) Battalion of the Dutch Armed Forces. In his civilian position, he is at this moment developing with MT-Derm in Berlin (Germany) a novel intradermal vaccination technology as well as a new therapy for cutaneous leishmaniasis for which he has won a Canadian ‘Grand Challenge’ grant. With Hemanua in Dublin (Ireland) he has developed an innovative blood separation unit, which is also suitable to produce convalescent plasma for Ebola Virus Disease therapy. He has finished both his studies in Medicine and in Biochemistry in The Netherlands with a doctorate and has extensive practical experience in cell biology, immuno-hematology, infectious diseases, biodefense, and transfusion medicine. His natural business acumen and negotiation competence help to initiate new successful businesses, often generated from unexpected combinations of technologies. He consults at top level management, in which his good understanding of abstract science combined with excellent skills in communication of scientific matters to non-specialists helps to get things done.

Infectious Diseases

Tonya Winders is currently the President and Chief Executive Officer of Allergy & Asthma Network, the leading patient advocacy organization dedicated to ending the needless death and suffering due to asthma, allergies and related conditions. Tonya has over 18 years experience in leadership roles within the allergy and asthma industry. From sales and marketing leadership to managed markets access, she has worked tirelessly to ensure patients have access to effective diagnostic and treatment tools. Tonya serves on several expert panels including the ATS Public Advisory Roundtable & the GINA/GOLD guidelines as the patient reviewer. Furthermore, she is on the board of directors for Not One More Life, American Respiratory Care Foundation and is the current president of the Global Allergy Asthma Patient Platform, representing more than 40 patient organizations throughout the world. Personally, Tonya is the mother of five children, four of whom have asthma and/or allergies, ranging in age from 13-20 years old. She enjoys spending time with her husband of 23 years Brian Winders and cheering on her children in various sports.

.

Kimihiko Okazaki was born in Osaka in 1933 and he completed his graduation from Kyoto University Faculty of Medicine in 1959. He engaged in Medical Chemical research from April 1960 to July 1981. He started engaging in Internal Medicine in July 1981. Then he started running a private medical clinic in September 1989. Main achievements are as follows: 1. Discovery of a novel coenzyme of thiamine pyrophosphokinase in Baker’s yeast. 2. Identification of initiator of rat liver regeneration as biliverdin. and 3. Discovery of a novel and complete cure-method for allergic and autoimmune diseases.

Immunology

I am Dr. Mojtaba Mafi M.D., Medical Doctor/ Physician, Graduate of Tehran University, School of Medicine with honor. I passed postgraduate courses on Nutrition, Gastroenterology and Hepatology, Obesity treatment and diabetes approved by Medical sciences university successfully. I am associate of Iran Hepatitis Network and Gastroenterology and Hepatology research center, Middle East Liver Diseases Center (MELD). I studied on fatty liver and related metabolic disorders among Iranian families from 2015 and currently publishing the results of our study and research about fatty liver and hyperlipidemia, diabetes and nutrition as study director and clinician associate member of Hepatitis Network.

Gastroenterology, Hepatology